Shares of Jaguar Health (JAGX) are currently trading higher in the pre-market, as we recently reported that the company revealed the sale of $6 million in Mytesi royalties to a secured lender last week.
Get the hottest stocks to trade every day before the market opens 100% free. Click here now.
A pharmaceuticals company focused on developing sustainable, novel gastrointestinal products, and Jaguar Health Inc is currently commercial-stage.
Discover Tomorrow's Stocks Today!
When it comes to discovering hidden gems within the stock market, Stock Wire News has consistently provided invaluable insights. Stock Wire News invites you to explore their upcoming Wealth Building Report. This report will shine a spotlight on little-known companies with the potential for substantial growth in 2024, and it's completely FREE for a limited time.
Claim the free report now by clicking here and start discovering the hidden gems of the market
Sponsored
When it comes to discovering hidden gems within the stock market, Stock Wire News has consistently provided invaluable insights. Stock Wire News invites you to explore their upcoming Wealth Building Report. This report will shine a spotlight on little-known companies with the potential for substantial growth in 2024, and it's completely FREE for a limited time.
Claim the free report now by clicking here and start discovering the hidden gems of the market
Sponsored
Before the market opened today, Jaguar Health’s (JAGX) share was trading at an increased price of $0.833, which was higher by 16.08%. The average volume for the stock during the last three-month period was 30.40 million. However, its shares are trading at a distance of 82.52% from its 20-days Simple Moving Average.
Read More
- Tags: Jaguar Health, Jaguar Health stock, JAGX, JAGX stock
